HCG therapy in azoospermic men with lower or borderline testosterone levels and the prognostic value of Y-deletion analysis in its outcome.

MLA

Andrabi, Syed Waseem, et al. “HCG Therapy in Azoospermic Men with Lower or Borderline Testosterone Levels and the Prognostic Value of Y-Deletion Analysis in Its Outcome.” Andrologia, vol. 54, no. 1, Feb. 2022, p. e14251. EBSCOhost, https://doi.org/10.1111/and.14251.

APA

Andrabi, S. W., Saini, P., Joshi, M., Mehta, P., Makker, G. C., Mishra, G., & Rajender, S. (2022). HCG therapy in azoospermic men with lower or borderline testosterone levels and the prognostic value of Y-deletion analysis in its outcome. Andrologia, 54(1), e14251. https://doi.org/10.1111/and.14251

Chicago

Andrabi, Syed Waseem, Pallavi Saini, Meghali Joshi, Poonam Mehta, Girish Chandra Makker, Geetanjali Mishra, and Singh Rajender. 2022. “HCG Therapy in Azoospermic Men with Lower or Borderline Testosterone Levels and the Prognostic Value of Y-Deletion Analysis in Its Outcome.” Andrologia 54 (1): e14251. doi:10.1111/and.14251.